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Abstract
Objective
To determine the diagnostic accuracy and clinical utility of electromagnetic source imaging
(EMSI) in presurgical evaluation of patients with epilepsy.
Methods
We prospectively recorded magnetoencephalography (MEG) simultaneously with EEG and
performed EMSI, comprising electric source imaging, magnetic source imaging, and analysis of
combined MEG-EEG datasets, using 2 diﬀerent software packages. As reference standard for
irritative zone (IZ) and seizure onset zone (SOZ), we used intracranial recordings and for
localization accuracy, outcome 1 year after operation.
Results
We included 141 consecutive patients. EMSI showed localized epileptiform discharges in 94
patients (67%). Most of the epileptiform discharge clusters (72%) were identiﬁed by both
modalities, 15% only by EEG, and 14% only by MEG. Agreement was substantial between
inverse solutions and moderate between software packages. EMSI provided new information
that changed the management plan in 34% of the patients, and these changes were useful in
80%. Depending on the method, EMSI had a concordance of 53% to 89% with IZ and 35% to
73% with SOZ. Localization accuracy of EMSI was between 44% and 57%, which was not
signiﬁcantly diﬀerent fromMRI (49%–76%) and PET (54%–85%). Combined EMSI achieved
signiﬁcantly higher odds ratio compared to electric source imaging and magnetic source
imaging.
Conclusion
EMSI has accuracy similar to established imaging methods and provides clinically useful, new
information in 34% of the patients.
Classification of evidence
This study provides Class IV evidence that EMSI had a concordance of 53%–89% and
35%–73% (depending on analysis) for the localization of epileptic focus as compared with
intracranial recordings—IZ and SOZ, respectively.
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Epilepsy has a prevalence of 4–10/1,000 persons, and up to
30% do not respond to antiepileptic drugs.1 Surgery is
a therapeutic option for patients with drug-resistant focal
epilepsy.2 Depending on the ability to localize and resect the
epileptogenic zone, 30% to 85% of operated patients become
seizure-free.3
The greatest challenge in epilepsy surgery is the presurgical
evaluation. On their own, none of the methods can reliably
identify the epileptogenic zone. Therefore, a multimodal ap-
proach using semiology, EEG, and MRI is needed. These are
often supplemented with functional neuroimaging methods,
such as SPECT or PET.4 In diﬃcult cases, intracranial elec-
trodes are implanted.3
Advances in recording techniques and in signal analysis have
made it possible to estimate the source of the epileptiform
discharges (EDs) recorded by EEG (EEG source imaging: ESI)
and magnetoencephalography (MEG source imaging: MSI).4
In studies5,6 investigating the clinical utility of MSI (i.e., changes
in clinical decision-making, based onMSI), MSI led to a change
in the management plan in 21% to 33% of patients, and this was
associated with long-term seizure control. Large prospective
studies showed that ESI accurately estimated the location of the
epileptic focus,7,8 although its role in clinical decision-making
was not addressed in those studies.
It is possible to record MEG and EEG signals simultaneously,
and perform electromagnetic source imaging (EMSI), analyzing
both modalities either separately (ESI and MSI) or combined
(cEMSI). Despite numerous studies suggesting that these
methods are accurate, ESI and MSI are only implemented in
a few centers,5 and often EEG and MEG are not recorded
simultaneously. This is probably attributable to the lack of well-
designed, large, prospective, blinded studies addressing EMSI.
Many questions remain unanswered: What is the diagnostic
yield of simultaneousMEG and EEG recordings?Which inverse
solution is best? Do diﬀerent software packages and operators
give similar results? Can the methods accurately estimate the
source of the EDs? Do they provide nonredundant, clinically
useful information that changes and improves decision-making
in presurgical evaluation?
To elucidate the role of EMSI in presurgical evaluation, we
conducted a prospective, blinded study. We evaluated the
diagnostic yield of the 2 recorded modalities, inter-software
and -operator agreement, accuracy of source localization, and
its clinical utility. We designed the study and we reported it
according to the STARD (Standards for Reporting Diagnostic
Accuracy) criteria.9
Methods
Study design and patients
From April 2011 to June 2016, we prospectively recruited
consecutive patients undergoing presurgical evaluation, as
part of the Danish Epilepsy Surgery Program. All patients had
drug-resistant focal epilepsy, and for all patients, at least 2,
appropriately chosen and taken antiepileptic drugs had failed.
The intended sample size was ≥100 patients, based on pre-
vious studies.10 This number has proven to provide the ref-
erence standard in >50 patients undergoing intracranial
recording (ICR) or operation.11
Inclusion criteria were patients who underwent presurgical
evaluation and who gave their consent. There were no ex-
clusion criteria; data from all recruited patients were analyzed.
Standard protocol approvals, registrations,
and patient consents
The study was approved by the regional ethics committee
(case number 1-10-72-177-12) and patients gave their in-
formed written consent. Patients underwent presurgical
evaluation according to the investigation protocol approved
by the Danish Health Authority (data available from Dryad,
appendix 1, doi.org/10.5061/dryad.p4r01pq). This included
detailed history, semiology, and EEG from video-EEG mon-
itoring, MRI, and neuropsychological tests for all patients.
When decisions could not be made based on these data,
patients were referred to additional noninvasive investigations
(PET, EMSI) and ICRs (stereo-EEG).
Presurgical patients, in whom the multidisciplinary team
(MDT) reached a conclusion based on semiology, EEG, and
MRI, were recruited as part of the research study (arm A). In
these patients, EMSI was not part of the decision-making.
Patients with normal MRI or discordant data (semiology,
EEG, MRI) were referred to PET and EMSI as part of their
presurgical evaluation, before ICR (arm B). In these patients,
EMSI was part of the decision-making process.
Glossary
BESA = Brain Electrical Source Analysis; cEMSI = combined electromagnetic source imaging; DSM = distributed source
model; ECD = equivalent current dipole; ED = epileptiform discharge; EMSI = electromagnetic source imaging; ESI = EEG
source imaging; FDG = 18F-ﬂuorodeoxyglucose; FLAIR = ﬂuid-attenuated inversion recovery; FN = false negative; FP = false
positive; GLM = generalized linear model; ICR = intracranial recording; IZ = irritative zone; MDT = multidisciplinary team;
MEG = magnetoencephalography; MPRAGE = magnetization-prepared rapid-acquisition gradient echo; MSI = magneto-
encephalography source imaging; NPV = negative predictive value; OR = odds ratio; PPV = positive predictive value; SOZ =
seizure onset zone; TN = true negative; TP = true positive.
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For patients in arm B, theMDT had a 2-step decision process.
Decision was ﬁrst made blinded to EMSI, based on all other
data, and it was logged into the database. Decisions were
categorized as (1) stop (operation not oﬀered), (2) implan-
tation of intracranial electrodes (specifying their location), or
(3) operation (resective surgery). Then, a second decision
was made, based on new information (if any) provided by the
EMSI, weighted against all other data. Possible changes in the
management plan included any change from one of these
categories to another and change within category 2
(i.e., change in the planned intracranial electrode positions).
Simultaneous MEG and EEG recordings
MEG-EEG was recorded at Aarhus University Hospital, using
an Elekta Neuromag system (Elekta, Stockholm, Sweden).
MEG was recorded at 102 evenly distributed locations, with 3
sensors at each location (2 orthogonal planar gradiometers
and a magnetometer), giving a total of 306 channels. Con-
tinuous head position indicators were used. MEG data were
preprocessed oﬄine using the spatiotemporal signal space
separation method12 to suppress the residual interference and
to correct for head movements.
High-density EEG (64–80 electrodes) was recorded using
a nonmagnetic cap (EASYCAP) and additional electrodes
covering the inferior part of the head (cheek, inferior temporal
chain, and neck) in all patients with head circumference <60
cm and who could cooperate with the procedure. In other
patients, an array of 19 electrodes (10-20 system) or no EEG
was recorded. In addition, electrooculogram and ECG were
recorded. Electronic tracking of positions of electrodes and of
the head position coils were done using a Polhemus system
(Polhemus, Colchester, VT).13
Spontaneous activity (eyes closed, rest, supine position) was
recorded for 60 to 90 minutes (sampling frequency 1 kHz;
online bandpass 0.1–330 Hz) both for MEG and EEG. Data
were oﬄine bandpass ﬁltered at 0.5 to 70 Hz.
Electromagnetic source imaging
MEG-EEG was inspected for EDs by 2 trained experts (L.D.,
S.B.). Signals were analyzed using 2 commercially available
software packages, with European approval for medical use
(CE-mark). L.D. used the CURRY 7 Neuroimaging Suite
(Compumedics, Victoria, Australia). S.B. used BESA-
Research 6 (BESA, Gra¨felﬁng, Germany). Voltage maps and
magnetic ﬁeld maps were inspected, and EDs were grouped in
diﬀerent clusters when the topographic maps diﬀered. Then,
for each cluster, using the visually detected EDs as templates,
automated algorithms (template matching) scanned the
recordings, and detected EDs were visually checked. To im-
prove the signal-to-noise ratio, EDs with similar topography
were averaged.14
Sequential topographic maps were inspected in the time ep-
och of the ascending slope of the averaged waveforms for
change in topography indicating propagation. In addition,
principal components analysis was used to identify propaga-
tion.15 When propagation occurred, source imaging was done
ﬁrst at the onset epoch, and then at the peak. When propa-
gation was not identiﬁed, source imaging was done at the
middle third of the ascending slope.10 With both software
packages, 2 diﬀerent inverse solutions were applied: equiva-
lent current dipole (ECD) and a distributed source model
(DSM): sLORETA,16 with an anatomically constrained linear
estimation approach, assuming the sources were distributed in
the cerebral cortex in CURRY, and CLARA in BESA.8 ESI and
MSI were done with both software packages. In addition,
using CURRY, source modeling of both datasets (EEG-
MEG) was done (cEMSI).17
All analyses were performed using individual head models
from the patients’ MRIs, coregistered with the MEG-EEG
recording using ﬁducial landmark positions, electrode posi-
tions, and head position coils, digitized before the recording.
In CURRY, 3-compartment boundary element method (BEM)
head model was used.18 In BESA, an individual 4-layer ﬁnite
element method (FEM) head model was used.14 Figure 1
illustrates the steps of the EMSI.
EMSI was performed prospectively, blinded to clinical in-
formation and reference standard results.
Conventional neuroimaging methods
MRI and 18F-ﬂuorodeoxyglucose (FDG)-PET were per-
formed as part of the presurgical evaluation. The MRI
epilepsy protocol consisted until 2015 of a sagittal T1
3-dimensional (3D) magnetization-prepared rapid-acquisition
gradient echo (MPRAGE) sequence, coronal and axial ﬂuid-
attenuated inversion recovery (FLAIR) sequences, and
a coronal T2-weighted (W) fast spin-echo sequence. Cor-
onal and axial FLAIR and T2W sequences were performed
perpendicular to and in plane with hippocampus long-axis.
Since 2015, the protocol consisted of sagittal T1 3D
MPRAGE sequence, sagittal 3D FLAIR sequence, coronal
and axial T2W sequences, perpendicular and horizontal to
hippocampus long-axis, axial susceptibility-weighted image
sequence, axial diﬀusion-weighted image sequence, sagittal
T1 3D MPRAGE sequence, and axial T1W spin-echo se-
quence after IV contrast. All 3D sequences were recon-
structed in coronal and axial planes perpendicular and
horizontal to the hippocampus long-axis.
For PET, FDG was administered IV with the patient in
supine position and equipped with eye pads and earplugs.
PET scan was commenced 40 minutes after tracer in-
jection. PET scans were coregistered and displayed
superimposed on MRI sequences using a standard clinical
workstation and dedicated software supplied by the cam-
era vendor (Leonardo station using TrueD; and from 2013
syngo.via using MI Neurology, Siemens Medical Solutions,
Malvern, PA) who also provided access to age-matched
normal database comparison.
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Sublobar brain regions
EMSI, PET, andMRI localization results were prospectively
logged into the database, with localization scores at sublobar
level, corresponding to 64 categories. This included the
sublobar regions proposed by an international consensus
paper and IFCN (International Federation of Clinical
Neurophysiology) guideline.15,19 A descriptor of the side
(left/right/mesial) was added. When more than 2 in-
dependent foci were identiﬁed, and none of them had
a dominant activity, the result was scored as multifocal. A
focus was considered dominant if the number of EDs was
more than twice the number of EDs from all other foci. The
remaining categories were (1) normal and (2) not localiz-
able. Not localizable was when the ECD conﬁdence interval
or the distributed source analysis spanned over more than
one lobe.
Reference standard
Ideal reference standard lacks for source imaging in presur-
gical evaluation.6 Accurately localizing the generator of
interictal EDs (the irritative zone [IZ]) does not necessarily
imply that resection of that area will render the patient
seizure-free. Therefore, we used 2 diﬀerent sets of reference
standards: ICR and outcome after surgery (see below).
Outcome measures
First, the number of ED clusters recorded by only MEG and
only EEG were compared.
Figure 1Methodologic flowchart of EMSI
EMSI was performed using the following 4 steps: (1)
review of the magnetoencephalography and EEG
recordings and visual identification and marking of
EDs belonging to the same cluster. These EDs were
used for template-matching. Each detected spike was
visually checked and artifacts were discarded. (2) EDs
within each cluster were averaged to improve signal-
to-noise ratio (critical for spike onset activity relative
to the background activity).28 Sequential topographic
plots of the ascending phase and principal compo-
nents analysis was used to identify propagation. (3)
Individual head model was created for each patient,
and the EEG electrodes were aligned to the scalp. (4)
Source modeling was performed using 2 different
inverse-solution strategies: equivalent current dipole
and distributed source models where yellow indi-
cates maximum intensity. ED = epileptiform dis-
charge; EMSI = electromagnetic source imaging; IED =
interictal epileptiform discharge.
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Agreement between diﬀerent EMSI methods was calculated.
All comparisons were done at sublobar level.
Clinical utility of EMSI was deﬁned as the proportion of
patients in whom EMSI changed the decision of the MDT. A
change was deﬁned useful as follows: (1) change from stop to
ICR—the ICR localized the source; (2) change in implanta-
tion strategy—the electrode(s) implanted based on the EMSI
identiﬁed the source; (3) change from implantation to op-
eration without preceding implantation—the patient became
seizure-free (at 1-year postoperative follow-up).
For EMSI, PET and MRI, we calculated the following out-
come measures. Agreement with ICR: concordance with IZ
and concordance with the seizure onset zone (SOZ) were
determined using ICR as reference standard. Proportion of
patients with results concordant with the reference standard,
and agreement with this reference standard were calculated.
Sensitivity, speciﬁcity, localization accuracy, positive pre-
dictive value (PPV), and negative predictive value (NPV)
were determined using outcome 1 year after surgery as ref-
erence standard. Preoperative EMSI was coregistered with the
postoperative MRI; the source was considered concordant
with the resected site when the ECD and respectively the
maximum of the DSM was within the operation cavity. All
other results (localization outside the cavity, multifocal EDs,
normal recoding, not-localizable results) were considered
discordant. We categorized the localizations as follows: TP
(true positive)—concordant with the resection and seizure-
free; FP (false positive)—concordant with the resection and
not seizure-free; TN (true negative)—discordant with the
resection and not seizure-free; FN (false negative)—
discordant with the resection and seizure-free. We used the
following formula:
Sensitivity = TP=ðTP+ FNÞ
Specificity = TN=ðTN+FPÞ
Accuracy = ðTN+TPÞ=ðTP + FP +TN+FNÞ
PPV = TP=ðTP+ FPÞ
NPV = TN=ðTN+FNÞ
Surgical procedures were tailored to each patient, based on
the ﬁnal conclusion of the MDT.
We calculated the odds ratio (OR) of becoming seizure-free
when operation was concordant vs discordant with the lo-
calization of the index test: OR = (TP/FP)/(FN/TN).
Statistics
For assessment of agreement (κ) between EMSI methods,
software packages, and operators, and for assessment of
agreement between EMSI and ICR, we calculated Gwet
AC1.
20 We used this measure of agreement because it yields
more reasonable values than the Cohen κ in case of low-trait
prevalences.20 Interrater agreement was interpreted according
to the conventional groups: poor (κ < 0), slight (κ: 0.01–0.2),
fair (κ: 0.21–0.4), moderate (κ: 0.41–0.6), substantial (κ:
0.61–0.8), and almost perfect agreement (κ > 0.8).21
The eﬀect measures of sensitivity, speciﬁcity, PPV, NPV, con-
cordance with SOZ, localization accuracy, and their 95% con-
ﬁdence intervals were estimated using a generalized linear
model (GLM).22,23 Identity link function was used in the GLM
to compare index tests by means of the diﬀerences of the eﬀect
measure. Multiple observations per patient were considered in
the GLM by specifying the patient ID as a cluster. Analysis was
performed in StataCorp software release 14 (StataCorp LP,
College Station, TX) using the binreg function.
Classification of evidence
The study was designed to answer the following question:
What is the localization accuracy and clinical utility of EMSI in
presurgical evaluation of patients with drug-resistant focal
epilepsy?
The study was prospective and blinded. All patients who
underwent presurgical evaluation and who gave their in-
formed consent were recruited. Data from all recruited
patients were analyzed and evaluated. All patients had drug-
resistant focal epilepsy.
This study provides Class IV evidence that EMSI had a con-
cordance of 53%–89% and 35%–73% (depending on analy-
sis) for the localization of epilepsy as compared with
ICRs—IZ and SOZ, respectively.
Data sharing
Individual deidentiﬁed data, including localization results of
the imaging methods, reference standard localizations, and
outcome data will be shared, along with the following related
documents: study protocol and statistical analysis plan. Un-
restricted access to these data will be made available from the
day of the online publication of the article, until 2030, using
a publicly accessible repository (datadryad.org//) (Dryad
doi:10.5061/dryad.p4r01pq). During the review phase, the
data package is temporarily available via the following link:
datadryad.org/review?doi=doi:10.5061/dryad.p4r01pq.
Results
Figure 2 shows examples of EMSI. Source images coregistered
with postoperative MRIs are shown in data available from
Dryad (appendix 2, doi.org/10.5061/dryad.p4r01pq).
Figure 3 shows the ﬂowchart of presurgical evaluation of all
recruited patients.
Patients
One hundred forty-one consecutive patients (59 females)
were included. Median age was 32 years (range: 8–70). All
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patients had MRI and MEG. Simultaneously with MEG, 115
patients had high-density EEG (64–80 electrodes). Because
of large head circumference or inability to cooperate, 8
patients had an array of 19 EEG electrodes and 18 patients did
not have EEG. One hundred ten patients had PET. MRI
showed potentially epileptogenic lesions in 68 patients (48%).
PET showed a functional deﬁcit zone in 70 patients (63%).
Seventy-two patients had temporal foci and 66 had extra-
temporal foci (frontal 50, parietal 11, occipital 5). Three
patients could not be localized. The time from MEG-EEG
recording to operation ranged from 1 to 48 months. No ad-
verse events occurred from performing MEG-EEG.
Detection of EDs by EEG and MEG
EMSI showed focus localized to one or more sublobar regions
in 94 patients (67%). The remaining patients had normal
MEG-EEG (46 patients; 33%) or the source was not local-
izable (one patient). See data available from Dryad, appen-
dices 3 and 4, doi.org/10.5061/dryad.p4r01pq.
In patients who had simultaneous MEG and EEG recordings
(n = 123), a total of 96 clusters of EDs were identiﬁed in 85
patients (60% of all patients). In 72% (70/96), EDs were
visible both in MEG and EEG. In 15% (14/96), EDs were
visible only in EEG. In 13% (12/96), EDs were visible only in
MEG. There was no signiﬁcant diﬀerence in the number of
interictal foci detected only by EEG and only by MEG (p =
0.67). Of the 14 foci detected only by EEG, 9 were located in
the temporal lobe. Of the 12 foci detected only by MEG, 7
were temporal.
Agreement between EMSI methods
Between-software and -operator agreement: both for ECD
and for DSM, agreement between BESA and CURRY was
moderate, for both modalities (ESI or MSI) (table 1).
Agreement in localization between the 2 inverse solution
strategies (ECD and DSM) within the same software and
operator: using BESA, there was almost perfect agreement
for MSI and substantial agreement for ESI (table 1). When
using CURRY, there was substantial agreement between
ECD and DSM for both modalities (ESI and MSI)
(table 1).
Clinical utility of EMSI
The eﬀect of EMSI on patient management planning was
assessed in 85 patients (50 males; age: 10–70, median 32
years) in whom EMSI was part of the decision-making pro-
cess. In this subgroup, 38 patients were MRI-negative; in the
remaining patients, there were discordances between MRI
and data from long-term video-EEG monitoring (semiology
and EEG).
In 34% (29/85), EMSI changed the management plan.
Figure 4 shows the types of changes in the management plan,
based on EMSI. At 1-year follow-up, reference standard was
available for 20 patients (5 patients did not wish to proceed
with ICR, one patient withdrew before operation, and 3
patients were still on the waiting list). In 80% (16/20), these
changes proved to be useful: in 4/4 patients who proceeded to
implantation based on EMSI, IZ and SOZ had been identi-
ﬁed; in 8/10 patients in whom additional electrodes were
implanted, the additional electrodes identiﬁed IZ and SOZ;
4/6 patients who skipped implantation and proceeded to
operation became seizure-free. See data available from Dryad,
appendix 5, doi.org/10.5061/dryad.p4r01pq.
Concordance with ICR
Fifty-three patients (34 males; age: 8–60, median 40 years)
underwent ICR; 25 were MRI-negative. Twenty-nine patients
had temporal foci and 24 had extratemporal foci (frontal 16,
Figure 2 Electromagnetic source imaging
Electromagnetic source imaging (equivalent current dipole and distributed source model) for a patient with frontal (A and B) and temporal (C and D) focus.
Analysis was done using CURRY (A and C) and BESA (B and D) software. Figures in appendix 2 (data available from Dryad, doi.org/10.5061/dryad.p4r01pq)
show preoperative sources coregistered with postoperative MRI for these patients.
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parietal 6, occipital 2). SOZ could not be localized by ICR in
14 of 53 patients.
Concordance between EMSI and the IZ was between 53%
and 89% (table 2). For ECD, this was higher in BESA than in
CURRY, both for EEG (p = 0.0003) and MEG (p = 0.0107);
for DSM, there was no signiﬁcant diﬀerence between the 2
software packages. Concordance with IZ was higher for most
of the EMSI methods than for MRI (50%; 31%–69%) and for
PET (29%; 13%–45%) (data available from Dryad, appen-
dices 6 and 7, doi.org/10.5061/dryad.p4r01pq).
Agreement between BESA EMSI and IZ was substantial.
Agreement between CURRY MEG DSM and IZ was
substantial; for the other CURRY EMSI, it was moderate
(table 3). Agreement with IZ was moderate for MRI and fair
for PET (table 3).
Concordance with SOZ for the EMSI methods was between
35% and 73% (table 2). For ECD, this was higher in BESA
than in CURRY both for EEG (p = 0.003) and MEG (p =
0.002). For DSM, there was no diﬀerence between the 2
software packages. Concordance with SOZ for CURRY DSM
cEMSI and CURRY ECD MEG was signiﬁcantly higher than
forMRI (p = 0.036 and p = 0.029, respectively) (data available
from Dryad, appendix 6, doi.org/10.5061/dryad.p4r01pq).
Concordance with SOZ for CURRY ECD MEG was higher
than for PET (p = 0.033). Concordance with SOZ for the
Table 1 Agreement between electromagnetic source
imaging methods
MEG EEG
BESA vs CURRY
ECD 0.58 (0.48–0.69) 0.47 (0.34–0.58)
DSM 0.58 (0.49–0.68) 0.43 (0.33–0.54)
BESA
ECD vs DSM 0.85 (0.78–0.91) 0.72 (0.63–0.82)
CURRY
ECD vs DSM 0.71 (0.62–0.80) 0.63 (0.52–0.73)
Abbreviations: DSM = distributed source model; ECD = equivalent current
dipole; MEG = magnetoencephalography.
Between-software and -operator agreement (BESA vs CURRY) and agree-
ment between inverse solution strategies (ECD vs DSM) within the same
software and operator. Data represent κ values (confidence intervals).
Figure 4 Clinical utility of EMSI
In 34% of patients (29/85), EMSI changed the management plan. The
changes were distributed as follows: stop → implantation of intracranial
electrodes, 6/85 (7%); implantation→ stop 1/85 (1%), change in the location
of implanted electrodes, 14/85 (16.5%); skipping implantation and going
directly to operation, 8/85 (9.4%). EMSI = electromagnetic source imaging; IC
= intracranial electrodes.
Figure 3 Flowchart of the presurgical evaluation for the 141
recruited patients
Red arrows and boxes indicate that operation was not offered and green
arrows andboxes indicate that operationwas indicated, by theMDT. *At this
stage in the flowchart, the MDTmade 2-step decisions: first blinded to EMSI,
then including EMSI results. **One patient died of acute myocardial in-
farction and one patient died of sudden unexpected death in epilepsy. EMSI
= electromagnetic source imaging; ICR = intracranial recording; MDT =
multidisciplinary team; OP = operation.
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Table 2 Performance of electromagnetic source imaging, MRI, and PET in presurgical evaluation
Reference standard ICR Seizure-free patients 1 y after operation
Outcome measure Concordance with IZ, % Concordance with SOZ, % Sensitivity, % Specificity, % PPV, % NPV, % Localization accuracy, % Odds ratio
CURRY ECD EEG 56 (37–74) 35 (14–56) 10 (0–22) 90 (78–100) 60 (17–100) 42 (28–57) 44 (30–58) 1.3 (0.2–7.2)
CURRY DSM EEG 73 (56–90) 50 (28–72) 17 (3–31) 90 (78–100) 71 (38–100) 44 (29–59) 48 (34–62) 0.8 (0.1–5.6)
CURRY ECD MEG 65 (48–81) 35 (15–55) 33 (16–50) 90 (78–100) 83 (62–100) 49 (33–65) 57 (43–71) 4.7 (0.7–30.8)
CURRY DSM MEG 84 (72–96) 67 (48–86) 43 (25–61) 76 (58–95) 72 (51–93) 48 (31–66) 57 (43–71) 2.0 (0.4–10.3)
CURRY ECD cEMSI 53 (31–71) 36 (16–67) 31 (14–48) 81 (64–98) 69 (44–95) 46 (30–62) 52 (38–66) 5.8 (0.9–36.4)
CURRY DSM cEMSI 80 (66–94) 64 (43–84) 38 (20–56) 76 (58–95) 69 (46–92) 47 (30–64) 54 (40–68) 19.2 (1.8–204.7)
BESA ECD EEG 87 (75–99) 73 (54–92) 31 (14–48) 71 (52–91) 60 (35–85) 43 (26–59) 48 (34–62) 1.0 (0.2–5.2)
BESA DSM EEG 74 (59–90) 64 (43–84) 34 (17–52) 71 (52–91) 63 (39–86) 44 (27–61) 50 (36–64) 0.5 (0.1–3.2)
BESA ECD MEG 89 (78–99) 65 (45–85) 43 (25–61) 76 (58–95) 72 (51–93) 48 (31–66) 57 (43–71) 3.0 (0.6–15.1)
BESA DSM MEG 82 (69–95) 63 (43–82) 43 (25–61) 76 (58–95) 72 (51–93) 48 (31–66) 57 (43–71) 3.6 (0.7–17.4)
MRI 50 (31–69) 37 (15–89) 67 (50–84) 57 (36–79) 69 (52–86) 55 (34–76) 63 (49–76) —
PET 29 (13–45) 39 (16–62) 59 (35–82) 81 (62–100) 77 (54–100) 65 (44–86) 70 (54–86) —
Abbreviations: cEMSI = combined electromagnetic source imaging; DSM = distributed source model; ECD = equivalent current dipole; ICR = intracranial recording; IZ = irritative zone; MEG = magnetoencephalography; NPV =
negative predictive value; PPV = positive predictive value; SOZ = seizure onset zone.
Data represent proportion (95% confidence interval). Since none of the seizure-free patients were operated discordant to MRI or PET, odds ratio could not be determined for these methods.
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remaining EMSI methods did not diﬀer from PET (data
available from Dryad, appendix 7). Agreement between SOZ
and DSM cEMSI in CURRY and between SOZ and bothMSI
methods in BESA (ECD and DSM) was moderate. The
remaining EMSI analysis, MRI, and PET had a fair agreement
with SOZ (table 3).
Operated patients
Of the 57 patients who had resective surgery, 51 patients (27
males; age: 8–62, median 62 years) were operated more than
1 year ago (ﬁgure 3). Thirty-one patients had temporal foci
and 20 had extratemporal foci (frontal 15, parietal 3, occipital
2). The median time from MEG-EEG recording to operation
was 10 months (range: 1–48 months). Thirty patients (59%)
were seizure-free at 1-year postoperative follow-up (ﬁgure 3).
Table 2 summarizes the measures determined from the op-
eration outcome: sensitivity, speciﬁcity, PPV, NPV, and lo-
calization accuracy. See data available fromDryad, appendices
6 and 7, doi.org/10.5061/dryad.p4r01pq.
Localization accuracy (proportion of TPs and TNs) of EMSI
methods was between 44% and 57%. There was no signiﬁcant
diﬀerence in localization accuracy among the EMSI methods
and between the EMSI methods and MRI. There was no
signiﬁcant diﬀerence between the localization accuracy of
PET and EMSI in BESA and cEMSI in CURRY.
Sensitivity of EMSI methods was between 10% and 43%
(table 2). For ESI using ECD, sensitivity was signiﬁcantly
higher in BESA than in CURRY (p = 0.02). There was no
signiﬁcant diﬀerence in sensitivity among the other EMSI
methods. Sensitivity of MRI (67%; 50%–84%) was signiﬁ-
cantly higher thanmost EMSImethods, except forMSI (ECD
and DSM) using BESA and DSM of MEG-EEG signals using
CURRY. There was no signiﬁcant diﬀerence in sensitivity
between PET (59%; 35%–82%) and DSMs (cEMSI in
CURRY, MEG in CURRY and BESA, EEG in BESA) and
between PET and ECD ESI in BESA. PET had signiﬁcantly
higher sensitivity than the other EMSI methods. See data
available from Dryad, appendices 6 and 7, doi.org/10.5061/
dryad.p4r01pq.
Speciﬁcity of EMSI methods was between 71% and 90%
(table 2). ESI in BESA had signiﬁcantly higher speciﬁcity than
using CURRY. Speciﬁcity was higher for all EMSI methods
than MRI (57%; 36%–79%), and this was statistically signif-
icant for all methods except for cEMSI. There was no sig-
niﬁcant diﬀerence in speciﬁcity between EMSI methods and
PET. See data available from Dryad, appendices 6 and 7, doi.
org/10.5061/dryad.p4r01pq.
EMSI had PPV between 60% and 83% and NPV between
42% and 49% (table 2). There was no signiﬁcant diﬀerence
in PPV among the EMSI methods and between the EMSI
methods and conventional neuroimaging methods (MRI
and PET). In addition, there was no signiﬁcant diﬀerence
between NPV of MRI and EMSI. NPV of PET was higher
than that of EMSI. This was signiﬁcant compared to ESI and
MSI in CURRY, the cEMSI analysis (ECD) in CURRY, and
for the analysis of EEG using ECD in BESA. See data
available from Dryad, appendices 6 and 7, doi.org/10.5061/
dryad.p4r01pq.
Since none of the seizure-free patients were operated dis-
cordant to MRI or PET, OR could not be determined for
these methods. There was no signiﬁcant diﬀerence in OR of
ESI and MSI between the 2 software packages. OR for MSI
was between 2 and 4.7 and for ESI from 0.5 to 1.25 (data
available from Dryad, appendix 8, doi.org/10.5061/dryad.
p4r01pq). Combining both EEG and MEG signals (cEMSI)
gave an OR of 5.8 for ECD and 19.2 for DSM (table 2). OR of
cEMSI using DSMwas signiﬁcantly higher than both ESI (p =
0.02) and MSI (p = 0.03).
Additional data with the distribution of the results in diﬀerent
lesion types and locations (temporal vs extratemporal) are
available from Dryad (appendix 9, doi.org/10.5061/dryad.
p4r01pq).
Discussion
More than one-fourth (28%) of the ED clusters were visible in
only one modality (MEG: 13%; EEG: 15%). Thus, although
most clusters were visible in both modalities, in order to re-
cord all clusters, simultaneous MEG and EEG recording is
Table 3 Agreement between imaging methods and
intracranial recording
Agreement with IZ Agreement with SOZ
CURRY ECD cEMSI 0.58 (0.38–0.78) 0.38 (0.20–0.58)
CURRY DSM cEMSI 0.56 (0.38–0.73) 0.40 (0.22–0.58)
CURRY ECD MEG 0.49 (0.32–0.67) 0.33 (0.17–0.50)
CURRY DSM MEG 0.60 (0.43–0.77) 0.39 (0.24–0.55)
CURRY ECD EEG 0.58 (0.38–0.77) 0.27 (0.10–0.45)
CURRY DSM EEG 0.56 (0.38–0.73) 0.30 (0.14–0.49)
BESA ECD MEG 0.63 (0.47–0.80) 0.42 (0.24–0.58)
BESA DSM MEG 0.61 (0.45–0.78) 0.41 (0.25–0.60)
BESA ECD EEG 0.71 (0.52–0.87) 0.33 (0.16–0.51)
BESA DSM EEG 0.71 (0.51–0.88) 0.34 (0.15–0.55)
MRI 0.41 (0.13–0.69) 0.32 (0.06–0.56)
PET 0.32 (0.11–0.57) 0.32 (0.12–0.57)
Abbreviations: cEMSI = combined electromagnetic source imaging; DSM =
distributed source model; ECD = equivalent current dipole; IZ = irritative
zone; MEG = magnetoencephalography; SOZ = seizure onset zone.
Data represent κ values (95% confidence intervals).
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needed. EMSI showed focal epileptiform abnormalities lo-
calized at sublobar level in 67% of the patients.
Despite using standardized methodology, variability in-
troduced by diﬀerent software packages and operators was
higher than the variability introduced by using diﬀerent in-
verse solutions (ECD vs DSM) by the same operator, in the
same software. This calls for further standardization.
EMSI methods achieved substantial agreement with IZ,
but only moderate with SOZ (MSI and cEMSI). This is not
surprising, since EMSI analyzed interictal EDs, which is
the IZ. Although IZ is often in the same region as SOZ,
ICR clearly showed24 that this is not always the case.
Previous studies suggested that the “dominant” cluster of
interictal discharges is concordant with the SOZ.7 How-
ever, these studies did not deﬁne what was “dominant.”
Although we have prospectively deﬁned what we consid-
ered dominant clusters, we found that source imaging of
interictal discharges correlated better with IZ than
with SOZ.
Using postoperative outcome as reference standard, we found
that the accuracy of EMSI was not signiﬁcantly diﬀerent from
MRI (none of the EMSI methods) and from PET (MSI in
BESA and cEMSI in CURRY). Although sensitivity of MRI
was higher than most EMSI methods, its speciﬁcity was lower
than EMSI. There was no signiﬁcant diﬀerence in sensitivity
and speciﬁcity between most EMSI methods and PET. Using
DSM for analyzing the combined dataset of MEG and EEG
yielded signiﬁcantly higher OR than separate analysis of both
datasets. This further emphasized the clinical importance of
recording MEG and EEG simultaneously.
The accuracy of EMSI was relatively low, though similar to the
conventional neuroimaging methods. Localizing the epilep-
togenic zone is extremely diﬃcult, and there is no single
method that on its own is suﬃcient for the presurgical eval-
uation. Although in the whole group of patients, the accuracy
of EMSI was not signiﬁcantly diﬀerent from conventional
neuroimaging, these methods complemented each other,
since EMSI was able to localize the source in cases in which
the conventional methods did not: EMSI provided new in-
formation that changed patients’ management plan in one-
third of the individual cases. In 80%, these changes proved to
be useful at 1-year follow-up. This demonstrates the role of
EMSI in the multimodal presurgical evaluation of patients
with drug-resistant focal epilepsy.
This study has several limitations. Almost all patients in whom
EMSI was part of the clinical workup consented to the study
(normal MRI or discordant MRI, EEG, and semiology).
However, this was not the case for patients whose decision
about operation was reached based on concordant MRI, EEG,
and semiology and where EMSI was not part of the clinical
workup. Thus, more complex cases might be overrepresented
in our study.
All patients were undergoing a presurgical evaluation in the
Danish national epilepsy surgery program, and all MEG-EEG
were recorded and analyzed at Aarhus University Hospital.
Although we addressed the variability introduced by 2 dif-
ferent software packages and analyzers, our study is single-
center.
Perfect reference standard lacks for presurgical evaluation.6
Because of spatial sampling problems, ICRs can be mis-
leading. However, using resection site and postoperative
outcome as reference standard has its drawbacks too: despite
correct localization of IZ and SOZ, patients might not become
seizure-free, since IZ and SOZ do not necessarily coincide
with the epileptogenic zone. Therefore, we opted for using
both datasets as reference standard, and here we emphasize
the intrinsic limitations of both approaches.
Our high-density EEG array recorded simultaneously with the
MEG was between 64 and 80 electrodes. Although some
studies suggested that at least 128 electrodes are needed for
optimal ESI,7 other studies failed to ﬁnd increase in accuracy
beyond 64 electrodes.25 However, not only the number of
electrodes matters, but also their distribution (even spatial
sampling) and coverage of inferior parts of the head (cheek
and neck). Our electrode array was in accordance with these
principles.
Previous studies using simulated data, somatosensory
responses and a case study, emphasized the importance of
individual realistic conductivity estimations for combined
EEG and MEG source analysis.17,26,27 Because of the com-
plementary nature of the 2 modalities and the increased
number of sensors, superior spatial resolution was achieved.
This is in line with our ﬁndings that the OR was highest for
cEMSI.
The evidence provided by this study is classiﬁed as Class IV,
because implantation of intracranial electrodes was not blin-
ded to the results of the EMSI and <80% of the patients had
been implanted or operated. Since locations shown by EMSI
need to be implanted for validation, it is technically impossible
to do this blinded to the EMSI. Furthermore, typically less
than half of the patients entering presurgical evaluation are
implanted or operated. Therefore, it is practically impossible
to achieve a higher class of evidence for diagnostic studies in
presurgical evaluation of patients with epilepsy.
Our results indicate that EMSI is as accurate as the well-
established neuroimaging methods and it provides clinically
useful, nonredundant information for the presurgical evalua-
tion of patients with epilepsy.
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